Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Jim Cramer Advises Caution on Cerebras Systems After IPO Surge Kevin Warsh Faces Divided Fed as Inflation Concerns Delay Rate Cut Timing SPS Commerce SPSC Q1 2026 Beat Revenue NA EPS Exceeds by Significant Amesite AMST Q1 2026 In Line Whats Next for Investors UK Exports to US Tumble 25 Amid Trump Tariff Shock Coinbase Announces 14 Workforce Reduction Amid Crypto Market Pressures Global Leaders Monitor TrumpXi Summit Amid Trade and Geopolitical Uncertainty Kingfisher Shares Rise as BQ Owner Weathers Easter Sales Dip Eyes Heatwave Boost US Jobless Claims Drop to Lowest Since MidMay Signaling Labor Market Strength Nebius Group to Present at BofA Global Technology Conference Potential Catalyst for AIFocused Firm Keysight Technologies Q1 2026 Earnings EPS Surges Past Estimates Stock Gains SREA Q1 2026 Earnings Slight EPS Miss Reflects Modest Operational Headwinds WLDN Q1 2026 Earnings EPS Beat of 749 Surprise Drives Slight Stock Uptick Vicor Corporation VICR Q1 2026 Earnings EPS Surges Past Estimates by Nearly 20 MSCI Q1 2026 Earnings Slight EPS Beat Amid Steady Demand for Index and Analytics ZIM Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Conditions ATIF Holdings ZBAI Holds Steady at 895 Amid Neutral Trading Session National Beverage Corp FIZZ Posts Modest Gain Amid Technical Consolidation Everest Group Ltd EG Holds Steady Near 353 as Insurance Sector Shows Mixed Signals Value Line Inc VALU Slips 138 as Stock Tests Key Support Level Japan Smaller Capitalization Fund JOF Slightly Lower Navigating Key Support Levels Alight Inc ALIT Surges 656 as Stock Tests Support Eyes Resistance at 098 Ball Corporation BALL Edges Higher as Packaging Sector Shows Stability Aldel Financial II Warrants ALDFW Hold Steady at 026 Amid Consolidation Chewy CHWY Holds Steady at Range Midpoint Amid Low Volatility EyePoint Inc EYPT Gains 486 as Stock Tests Resistance at 1449 OS Therapies OSTX Tests Support as Shares Decline Nearly 5